A community based seroprevalence of SARS-CoV-2 antibodies in Somali Region, Eastern Ethiopia

被引:0
|
作者
Yared, Solomon [1 ]
Abera, Tsegalem [2 ,7 ]
Ali, Seid Mohammed [3 ,4 ]
Muhummed, Abdifatah Muktar [4 ,5 ]
Ibrahim, Mohammed [2 ]
Hassan, Abdullahi [5 ]
Hattendorf, Jan [4 ]
Zinsstag, Jakob [4 ]
Tschopp, Rea [4 ,6 ]
机构
[1] Jigjiga Univ, Dept Biol, Coll Nat & Computat Sci, Jigjiga, Ethiopia
[2] Jigjiga Univ, Coll Vet Med, Dept Vet Microbiol & Publ Hlth, Jigjiga, Ethiopia
[3] Jigjiga Univ, Dept Anim & Range Sci, Coll Dryland Agr, Jigjiga, Ethiopia
[4] Univ Basel, Dept Epidemiol & Publ Hlth, Basel, Switzerland
[5] Jigjiga Univ, Coll Med & Hlth Sci, Sch Med, Jigjiga, Ethiopia
[6] Armauer Hansen Res Inst, One Hlth Unit, Addis Ababa, Ethiopia
[7] Jigjiga Univ, Coll Vet Med, Dept Vet Microbiol & Publ Hlth, POB 1020, Jigjiga, Ethiopia
关键词
community; SARS-CoV-2; seroprevalence; Somali Region; COVID-19;
D O I
10.1002/iid3.1148
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
BackgroundCoronavirus disease 19 (COVID-19) is life-threatening infectious disease caused by SARS-CoV-2 virus that caused a global pandemic. SARS-CoV-2 has been widely transmitted throughout Ethiopia, with over 501,060 cases confirmed and 7574 deaths until November 2023. This study assessed for the first time the seroprevalence SARS-CoV-2 in the general population of the Somali Region during the COVID-19 pandemic.MethodsA cross-sectional study design was conducted from May to June 2021 in 14 districts of Somali Region. Blood samples were collected in 820 participants in addition to administering a questionnaire that included sociodemographic characteristics and history of clinical symptoms of COVID-19. Blood samples were tested for the presence or absence of anti-SARS-CoV-2 using a commercial Enzyme-Linked Immunosorbent Assay (ELISA) kit (Euroimmun).ResultsOverall, 477 (58.2%) were male and 343 (41.8%) were female. The majority of the participants (N = 581; 70.9%) were between 18 and 34 years old and not vaccinated against COVID-19 (N = 793; 96.7%). The overall seroprevalence of SARS-CoV-2 antibodies was 41.7% (95% CI: 33.3%-47.6%). The highest prevalence was found in Goljano district (70%) and the lowest in Gunagado district (22.5%). Only age was found to be associated with COVID-19 seropositivity.ConclusionPrevalence of SARS-CoV-2 antibodies was the highest ever reported in Ethiopia, indicating that a large proportion of the population had been infected 14 months after the start of the outbreak in the country. Such studies are important to swiftly reassess and improve specific COVID-19 preventive and control measures to reduce transmissions within the community in a given setting. We conducted a cross-sectional study to estimate the seroprevalence of antibodies to SARS-CoV-2 in 820 participants from the general population of SRS during the COVID-19 pandemic and risk factors for disease and disease transmission The overall seroprevalence of COVID-19 was 41.7% (95% CI: 33.3%-47.6%). The highest prevalence was found in Goljano district (70%) and the lowest in Gunagado district (22.5%). Only age was found to be significantly associated with COVID-19 seropositivity. The high prevalence of COVID-19 combined with the low vaccination rate indicated that a large proportion of the population in SRS had been infected since the beginning of 2020 The key findings from the present study will have implications for shaping future epidemic control.image
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Seroprevalence of SARS-CoV-2 Antibodies in Africa: A Systematic Review and Meta-Analysis
    Hajissa, Khalid
    Islam, Md Asiful
    Hassan, Siti Asma
    Zaidah, Abdul Rahman
    Ismail, Nabilah
    Mohamed, Zeehaida
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (12)
  • [32] Seroprevalence of SARS-CoV-2 antibodies and associated risk factors during the second wave of infection in a university community in Cameroon
    Essomba, Rene Ghislain
    Bayibeki, Albert Ngano
    Lissom, Abel
    Ateba, Pulcherie Therese
    Seni, Nassif
    Fouda, Claude Ariane Nlozoa
    Mbitock, Solange Berthe Diwandja
    Ebonda, Normand David
    Afana, Sylvie Delphine
    Akame, Simeon
    Tembu, Adelphe Anyang
    Ngamaleu, Modeste Romuald
    Bimai, Bernard Christel Bihonba
    Kabo, Ousmane
    Nguwoh, Philipe Salomon
    Ngounouh, Christian Taheu
    Meka, Moise Christian Junior
    Kengne, Michel
    Likeng, Julienne-Louise Ngo
    Kimessoukie, Etienne Omolomo
    Nkoum, Benjamin Alexandre
    Assoumou, Marie Claire Okomo
    Fokam, Joseph
    Boum, I. I. Yap
    Ambomo, Myriam Sylvie
    Chadou, Michael Junior Piameu
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2023, 17 (11)
  • [33] SARS-CoV-2 seroprevalence among 7950 healthcare workers in the Region of Southern Denmark
    von Huth, Sebastian
    Lillevang, Soren Thue
    Roge, Birgit Thorup
    Madsen, Jonna Skov
    Mogensen, Christian Backer
    Coia, John Eugenio
    Moller, Soren
    Justesen, Ulrik Stenz
    Johansen, Isik Somuncu
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 112 : 96 - 102
  • [34] SARS-CoV-2 Seroprevalence at an Urban Hospital in Haiti
    Price, Robert
    Cho, Jeffrey
    Nelson, Scott
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (08)
  • [35] SARS-CoV-2 Antibody Seroprevalence in Jakarta, Indonesia
    Ariawan, Iwan
    Jusril, Hafizah
    Farid, Muhammad N.
    Riono, Pandu
    Wahyuningsih, Wiji
    Widyastuti, Widyastuti
    Handayani, Dwi Oktavia T. L.
    Wahyuningsih, Endang Sri
    Daulay, Rebekka
    Henderiawati, Retno
    Malik, Safarina G.
    Noviyanti, Rintis
    Trianty, Leily
    Fadila, Nadia
    Myint, Khin Saw Aye
    Yudhaputri, Frilasita A.
    Venkateswaran, Neeraja
    Venkateswaran, Kodumudi
    Udhayakumar, Venkatachalam
    Hawley, William A.
    Morgan, Juliette
    Pronyk, Paul M.
    KESMAS-NATIONAL PUBLIC HEALTH JOURNAL, 2022, 17 (03): : 169 - 174
  • [36] SARS-CoV-2 seroprevalence in the Vatican City State
    Ralli, Massimo
    Arcangeli, Andrea
    Soave, Paolo Maurizio
    Voglino, Maria Cristina
    De-Giorgio, Fabio
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2021, 86 : 98 - 99
  • [37] Nationwide Seroprevalence of SARS-CoV-2 in Saudi Arabia
    Alharbi, Naif Khalaf
    Alghnam, Suliman
    Algaissi, Abdullah
    Albalawi, Hind
    Alenazi, Mohammed W.
    Albargawi, Areeb M.
    Alharbi, Abdullah G.
    Alhazmi, Abdulaziz
    Al Qarni, Ali
    Alfarhan, Ali
    Zowawi, Hosam M.
    Alhatmi, Hind
    Alghamdi, Jahad
    Alroqi, Fayhan
    Batarfi, Khalid
    Arabi, Yaseen M.
    Hashem, Anwar M.
    Bosaeed, Mohammed
    Aldibasi, Omar
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2021, 14 (07) : 832 - 838
  • [38] Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers in a nonepidemic region, Japan: A hospital-based study on May, 2020
    Nakamura, Akihiro
    Ando, Sanae
    Endo, Hideaki
    Sato, Ryoichi
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (07) : 4608 - 4611
  • [39] Seroprevalence of SARS-CoV-2 Antibodies and Factors Associated with Seropositivity at the University of Salamanca: The DIANCUSAL Study
    Muro, Antonio
    Belhassen-Garcia, Moncef
    Munoz Bellido, Juan Luis
    Lorenzo Juanes, Helena
    Vicente, Belen
    Pendones, Josue
    Adserias, Jose
    Sanchez Hernandez, Gonzalo
    Rodriguez Rosa, Miguel
    Vicente Villardon, Jose Luis
    Burguillo, Javier
    Lopez Andaluz, Javier
    Martin Oterino, Jose Angel
    Garcia Criado, Francisco Javier
    Barbero, Fausto
    Morales, Ana Isabel
    Galindo Villardon, Purificacion
    Gonzalez Sarmiento, Rogelio
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (15)
  • [40] Seroprevalence and Correlates of SARS-CoV-2 Antibodies in Health Care Workers in Chicago
    Wilkins, John T.
    Gray, Elizabeth L.
    Wallia, Amisha
    Hirschhorn, Lisa R.
    Zembower, Teresa R.
    Ho, Joyce
    Kalume, Naomi
    Agbo, Ojoma
    Zhu, Alex
    Rasmussen-Torvik, Laura J.
    Khan, Sadiya S.
    Carnethon, Mercedes
    Huffman, Mark
    Evans, Charlesnika T.
    OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (01):